Joinn Laboratories(China)Co.,Ltd. (HKG: 6127)
Hong Kong
· Delayed Price · Currency is HKD
8.93
-0.42 (-4.49%)
Jan 2, 2025, 3:22 PM HKT
Joinn Laboratories(China)Co.,Ltd. Revenue
Joinn Laboratories(China)Co.,Ltd. had revenue of 485.80M CNY in the quarter ending September 30, 2024, a decrease of -15.51%. This brings the company's revenue in the last twelve months to 2.12B, down -17.61% year-over-year. In the year 2023, Joinn Laboratories(China)Co.,Ltd. had annual revenue of 2.38B with 4.78% growth.
Revenue (ttm)
2.12B CNY
Revenue Growth
-17.61%
P/S Ratio
n/a
Revenue / Employee
846.44K CNY
Employees
2,510
Market Cap
11.84B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.38B | 108.52M | 4.78% |
Dec 31, 2022 | 2.27B | 751.29M | 49.54% |
Dec 31, 2021 | 1.52B | 440.78M | 40.97% |
Dec 31, 2020 | 1.08B | 436.53M | 68.27% |
Dec 31, 2019 | 639.38M | 230.58M | 56.40% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
Hansoh Pharmaceutical Group Company | 13.00B |
JD Health International | 58.84B |
WuXi Biologics | 18.39B |
Sinopharm Group | 634.32B |
Innovent Biologics | 8.01B |
Sino Biopharmaceutical | 29.86B |
CSPC Pharmaceutical Group | 33.53B |